Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

72.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 159.60
  • 52 Week Low: 39.75
  • Currency: UK Pounds
  • Shares Issued: 359.04m
  • Volume: 1,268,111
  • Market Cap: £258.51m
  • RiskGrade: 461

Latest ShareCast News

Avacta Group appoints new non-executive chair

By Josh White

Date: Thursday 20 Jun 2024

(Sharecast News) - Life science company Avacta Group announced the appointment of Shaun Chilton as its non-executive chairman on Thursday, succeeding Eliot Forster, who was stepping down from the board with immediate effect.

Avacta reports further progress in chemotherapy trial

By Josh White

Date: Thursday 23 May 2024

(Sharecast News) - Avacta Group announced the successful completion of the first cohort and the start of dosing for three patients in the second cohort of the second arm in its phase one trial of AVA6000, a peptide drug conjugate form of doxorubicin chemotherapy, on Thursday.

Avacta reaches milestone in AVA6000 dose escalation

By Josh White

Date: Thursday 21 Mar 2024

(Sharecast News) - Avacta Group announced a significant milestone in its phase 1a dose escalation study of AVA6000, its lead 'preCISION' drug, on Thursday.

Avacta tumbles after raising £25.7m in heavily d... 29-Feb-2024 ShareCast
Avacta appoints new head of research and develop... 19-Jan-2024 ShareCast
Avacta appoints new chief business officer 19-Dec-2023 ShareCast
Avacta hails "encouraging" clinical data from ca... 13-Dec-2023 ShareCast
Avacta reports higher losses in first half 28-Sep-2023 ShareCast
Avacta brings in clinical consultant as it hunts... 20-Sep-2023 ShareCast
Avacta upbeat on fresh data from chemotherapy tr... 19-Sep-2023 ShareCast
Avacta completes fifth dose escalation in chemot... 21-Jun-2023 ShareCast
Avacta denies press speculation over potential f... 19-Jun-2023 ShareCast
Avacta triggers second milestone payment in Affy... 05-Jun-2023 ShareCast
Avacta buys Belgium-based Coris Bioconcept for £... 01-Jun-2023 ShareCast
Avacta doses first patient in US tumour treatmen... 27-Apr-2023 ShareCast
Revenue rises, adjusted EBITDA loss improves for... 25-Apr-2023 ShareCast
Avacta presents pre-clinical data for anti-cance... 17-Apr-2023 ShareCast
Avacta opens first US clinical investigator sites 06-Apr-2023 ShareCast
Avacta doses first patient in higher-dose oncolo... 05-Apr-2023 ShareCast
Avacta to present tumour medicine data at cancer... 27-Mar-2023 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 72.00p
Change Today 1.00p
% Change 1.41 %
52 Week High 159.60
52 Week Low 39.75
Volume 1,268,111
Shares Issued 359.04m
Market Cap £258.51m
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.56% below the market average36.56% below the market average36.56% below the market average36.56% below the market average36.56% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Price Trend
66.16% below the market average66.16% below the market average66.16% below the market average66.16% below the market average66.16% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
63.18% above the market average63.18% above the market average63.18% above the market average63.18% above the market average63.18% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:29 1,371 @ 72.25p
16:27 77 @ 72.00p
16:26 250 @ 71.10p
16:25 20,000 @ 71.08p
16:22 762 @ 71.10p

Avacta Group Key Personnel

CFO Tony Peter Gardiner
CEO Christina Coughlin

Top of Page